Information about Gefitinib
Gefitinib is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.
How gefitinib works
Gefitinib is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Common side effects of gefitinib
Nausea, Rash, Vomiting, Weakness, Loss of appetite, Dry skin, Diarrhoea, Stomatitis (Inflammation of the mouth)
Available Medicine for Gefitinib
- ₹1966 to ₹5900Natco Pharma Ltd2 variant(s)
- ₹4023Dr Reddy's Laboratories Ltd1 variant(s)
- ₹3002Zuventus Healthcare Ltd1 variant(s)
- ₹4166Glenmark Pharmaceuticals Ltd1 variant(s)
- ₹3706Intas Pharmaceuticals Ltd1 variant(s)
- ₹2139Fresenius Kabi India Pvt Ltd1 variant(s)
- ₹3285Biochem Pharmaceutical Industries1 variant(s)
- ₹3445Panacea Biotec Ltd1 variant(s)
- ₹3081Emcure Pharmaceuticals Ltd1 variant(s)
- ₹3330 to ₹9990Celon Laboratories Ltd2 variant(s)
Expert advice for Gefitinib
- Do not take antacids (to reduce the acid level of your stomach) 2 hours before or 1 hour after taking gefitinib.
- Take the tablet at about the same time each day.
- Do not give gefitinib to children.
- Do not take gefitinib, if you are allergic to gefitinib or similar medicines or to any of the other ingredients.
- Avoid using gefitinib, if you are pregnant or are breast-feeding.
- Avoid becoming pregnant during treatment with gefitinib because it could harm your baby.
- If you are taking a medicine containing warfarin as an active substance, your doctor may need to do blood tests more often.
- You may feel weak while taking this medicine, be careful while driving or using tools or machines.
Frequently asked questions for Gefitinib
Q. Is Gefitinib a monoclonal antibody?
No. It is not a monoclonal antibody.It is a tyrosine kinase inhibitors.